%0 Journal Article
%T The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM¦Á) paradigm: conceptual framework and therapeutic potential
%A Alberto Corsini
%A Alberto J. Lorenzatti
%A Alberto Zambon
%A Alexander Tenenbaum
%A Andrey V. Susekov
%A Andr¨¦ Tartar
%A Anne Tybj£¿rg-Hansen
%A Aruna Pradhan
%A Brian Tomlinson
%A B£¿rge G. Nordestgaard
%A Carlos Aguilar-Salinas
%A Carlos I. Ponte-Negretti
%A Chris J. Packard
%A Fredrik Karpe
%A Gerald F. Watts
%A Henry N. Ginsberg
%A Hisao Ogawa
%A Hitoshi Shimano
%A Jane K. Stock
%A Jean-Charles Fruchart
%A Jean-Pierre Despr¨¦s
%A Jesus Millan Nu£¿ez-Cortes
%A Jorge Plutzky
%A Kausik K. Ray
%A Khalid Al Rasadi
%A Koutaro Yokote
%A Lale S. Tokg£¿zo£¿lu
%A Marat V. Ezhov
%A Marja-Riitta Taskinen
%A Masanori Aikawa
%A Massimiliano Ruscica
%A Michal Vrabl¨ªk
%A Michel Farnier
%A Michel Krempf
%A Michel P. Hermans
%A Patrick Duriez
%A Paul M. Ridker
%A Paul Valensi
%A Peter Libby
%A Philip J. Barter
%A Pierre Amarenco
%A Piyamitr Sritara
%A Raul D. Santos
%A Richard Ceska
%A Robert H. Eckel
%A Ruth McPherson
%A Shaukat Sadikot
%A Shizuya Yamashita
%A Shun Ishibashi
%A Soo Lim
%A Ta-Chen Su
%A Tatsuhiko Kodama
%A Walter Wahli
%A Wolfgang Koenig
%A £¿eljko Reiner
%J Archive of "Cardiovascular Diabetology".
%D 2019
%R 10.1186/s12933-019-0864-7
%X The online version of this article (10.1186/s12933-019-0864-7) contains supplementary material, which is available to authorized users
%K Residual cardiovascular risk
%K Visceral obesity
%K Diabetes
%K Atherogenic dyslipidemia
%K Triglycerides
%K Remnant cholesterol
%K Selective peroxisome proliferator-activated receptor alpha modulator
%K SPPARMalpha
%K Pemafibrate (K-877)
%K Inflammation
%K PROMINENT
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549355/